These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8334683)

  • 1. In vivo modulation of natural killer cell activity by tamoxifen in patients with bilateral primary breast cancer.
    Robinson E; Rubin D; Mekori T; Segal R; Pollack S
    Cancer Immunol Immunother; 1993 Aug; 37(3):209-12. PubMed ID: 8334683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy.
    Murta EF; de Andrade JM; Falcão RP; Bighetti S
    Tumori; 2000; 86(5):403-7. PubMed ID: 11130570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of tamoxifen on parameters of cell-mediated immunity in postmenopausal patients with breast carcinoma].
    Mallmann P; Krebs D
    Zentralbl Gynakol; 1991; 113(12):689-96. PubMed ID: 1927118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous mixed lymphocyte reaction (AMLR) in man. XVI. The AMLR and monoclonal antibody-defined T cell subsets and HNK 1+ natural killer cells in normal human pregnancy.
    Gupta S; Fanous E
    J Reprod Immunol; 1986 Apr; 9(1):1-9. PubMed ID: 2946861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities in the T and NK lymphocyte phenotype in patients with Nijmegen breakage syndrome.
    Michałkiewicz J; Barth C; Chrzanowska K; Gregorek H; Syczewska M; Weemaes CM; Madaliński K; Stachowski J;
    Clin Exp Immunol; 2003 Dec; 134(3):482-90. PubMed ID: 14632755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of chemotherapeutic and endocrine intervention on natural killer cell activity in human breast cancer.
    Brenner BG; Margolese RG
    Cancer; 1991 Aug; 68(3):482-8. PubMed ID: 2065267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
    Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
    J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell activity, phagocytosis, and number of peripheral blood cells in breast cancer patients treated with tamoxifen.
    Lukac J; Kusić Z; Kordić D; Koncar M; Bolanca A
    Breast Cancer Res Treat; 1994; 29(3):279-85. PubMed ID: 8049462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of natural killer cell activity by tamoxifen in stage I post-menopausal breast cancer.
    Berry J; Green BJ; Matheson DS
    Eur J Cancer Clin Oncol; 1987 May; 23(5):517-20. PubMed ID: 3653175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
    Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired autologous mixed lymphocyte reaction (AMLR) reactivity of peripheral blood T cell subsets in rheumatoid arthritis.
    Keystone EC; Poplonski L; Snow KM; Martell M
    Clin Exp Immunol; 1989 Nov; 78(2):184-8. PubMed ID: 12412746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of mild acute stress on immune cell distribution and natural killer cell activity in breast cancer patients.
    van der Pompe G; Antoni MH; Visser A; Heijnen CJ
    Biol Psychol; 1998 May; 48(1):21-35. PubMed ID: 9676357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
    Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
    Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
    [No Abstract]   [Full Text] [Related]  

  • 14. Chagasic patients with indeterminate clinical form of the disease have high frequencies of circulating CD3+CD16-CD56+ natural killer T cells and CD4+CD25High regulatory T lymphocytes.
    Vitelli-Avelar DM; Sathler-Avelar R; Dias JC; Pascoal VP; Teixeira-Carvalho A; Lage PS; Elói-Santos SM; Corrêa-Oliveira R; Martins-Filho OA
    Scand J Immunol; 2005 Sep; 62(3):297-308. PubMed ID: 16179017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.
    Muraro E; Comaro E; Talamini R; Turchet E; Miolo G; Scalone S; Militello L; Lombardi D; Spazzapan S; Perin T; Massarut S; Crivellari D; Dolcetti R; Martorelli D
    J Transl Med; 2015 Jun; 13():204. PubMed ID: 26116238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
    Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
    J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of natural killer (NK) receptors on NK (CD3-/CD56+), T (CD3+/CD56-) and NKT-like (CD3+/CD56+) cells after heart transplantation.
    Aguilar P; Mathieu CP; Clerc G; Ethevenot G; Fajraoui M; Mattei S; Faure GC; Bene MC
    J Heart Lung Transplant; 2006 Feb; 25(2):200-5. PubMed ID: 16446221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer activity in patients with breast cancer.
    Bonilla F; Alvarez-Mon M; Merino F; Girón JA; Menéndez JL; Espana P; Durántez A
    Eur J Gynaecol Oncol; 1990; 11(2):103-9. PubMed ID: 2379508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunological status of breast cancer patients during treatment with a new antiestrogen, toremifene.
    Valavaara R; Tuominen J; Toivanen A
    Cancer Immunol Immunother; 1990; 31(6):381-6. PubMed ID: 2143689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective autologous mixed lymphocyte reaction (AMLR) and killer activity generated in the AMLR in cancer patients.
    Iwahashi M; Tanimura H; Yamaue H; Tsunoda T; Tani M; Tamai M; Noguchi K; Hotta T
    Int J Cancer; 1992 Apr; 51(1):67-71. PubMed ID: 1532952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.